LINC01553

Across TCGA pan-cancer cohorts, LINC01553 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated LINC01553 data layer compared with 9 for mass-spec protein.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher LINC01553 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01553 expression acts as an unfavorable survival marker.

LIHC and TGCT are the cancer types where LINC01553 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Median	All	0.098	0.777	<.001	12	view →
TGCT	DFS	Median	All	0.151	0.801	.026	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

LINC01553–LIHC (OS)

Open the LIHC breakdown →